Placebo vs Nocebo Effect on Migraine Treatment
Posted on December 09 2023,

Category | Placebo Effect | Nocebo Effect |
---|---|---|
Definition | An inactive treatment that leads to improvement in migraine due to positive patient expectations. | A treatment (inactive or active) that leads to worsening of migraine or the presence of adverse effects due to negative patient expectations. |
Incidence in clinical trials | Up to 32.4% for acute treatments Up to 30.4% for preventives |
Up to 18.4% for acute treatments Up to 47% for preventives |
Enhancing Factors | Positive doctor-patient relationship, parenteral route (especially surgery), specific drug mechanisms, branding/marketing, prior positive experiences. | Psychiatric comorbidities, chronic migraine, prior treatment failures, generic medications, observation of side effects in others. |
Psychological Basis | Expectation of benefit, motivation, and reward circuits. | Expectation of harm, fear, and avoidance circuits. |
Physiological Basis | Activation of descending pain pathways and dopamine reward circuits in the brain. | Increased activity in brain regions processing fear, anxiety and pain sensations. |
Clinical Importance | Maximizing placebo can improve patient outcomes and treatment effectiveness. | Minimizing nocebo can improve patient outcomes and treatment compliance. |
Modifiability | Can be enhanced through empathy, reassurance, positive framing by healthcare providers. | Can be minimized through empathy, reassurance about side effects, careful adverse event reporting. |
Fri, Jul 11, 25
Migraine and Depression: Shared Brain Mechanisms
Learn why migraine and depression are linked through shared brain pathways. 2025 research reveals genetic connections and dual-action treatments for both.
Read MoreMon, Jul 07, 25
Chronic Pain and Brain Gene Expression
New study proves chronic pain is biological. Brain immune cells drive pain, offering hope for targeted migraine and chronic pain treatments.
Read MoreSat, Jul 05, 25
Migraine & White Matter Hyperintensities
Migraine and white matter hyperintensities: Recent studies show NO association. Large-scale 2023-2025 research contradicts older findings. Important clinical implications explained.
Read More